XOMA Royalty

Royalty Pharma

This company provides capital to biopharmaceutical firms and academic institutions in exchange for royalty interests in approved and late-stage medical treatments.

Roivant

This biotech company develops and commercialises medicines and healthcare technologies for patients through its specialised subsidiary companies.

Molecule

This company develops a decentralized science platform for funding and tokenising intellectual property to connect researchers with biotech investors.

X4 Pharmaceuticals

This biopharmaceutical company develops and commercialises oral therapies for patients with rare immune system disorders, such as WHIM syndrome and chronic neutropenia.

Xontogeny

This life sciences accelerator provides seed investment and strategic operational support to early-stage healthcare companies developing therapeutics, diagnostics and medical devices.

Nuvalent

This biopharmaceutical company develops targeted small molecule kinase inhibitors for patients with genomically defined cancers such as non-small cell lung cancer.

1200 Pharma

This biotechnology firm develops small molecule therapies and drug intellectual property for the treatment of cancer patients.

EXO Therapeutics

This biotechnology company develops small-molecule drugs targeting enzyme exosites for healthcare institutions and pharmaceutical partners to treat oncology and inflammatory diseases.